Protocol Ledger

NCT05351801 · Phase II · RECRUITING

Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain

Interventional Phase II clinical trial protocol NCT05351801 sponsored by VA Office of Research and Development in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-06-21 Enrollment: 320 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05351801
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)320 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05351801
Protocol FieldVerified Registry Value
NCT IdentifierNCT05351801
Consolidated Lead SponsorVA Office of Research and Development
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment320 participants (ESTIMATED)
Registered Start Date2023-06-21
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI